Microbiome Medicine Center (MMC) is a microbiome research institute established by Southern Medical University and Zhujiang Hospital. MCC aims to uncover the underlying mechanisms in microbiome-host interactions as well as translating those knowledges into novel clinical diagnostic and treatment approaches. In the past three years, MMC has made a series of progresses studying the role of microbiome in disease diagnostic models, metabolic diseases and perinatal diseases and these works have been published in Cell, Nature Medicine (cover story), Gut (cover story), Journal of Hepatology, Microbiome and etc.
Postdoctoral positions are available now, and indefinitely, in MMC. MMC is interested in the role of microbiome in aging related diseases, metabolic diseases, stroke, cancer, maternal and infant's health, infectious diseases as well as in multi-omics data analysis, bioinformatics and disease diagnosis. Accordingly, MMC has a complete set of apparatus facilitating microbiome researches, including platforms for microbiome sample processing, big data analysis high-performance cluster, human studies, animal and functional experiments, microbes isolation and etc.
Prof. Zhou Hongwei received NSFC funding for the program“Basic Research on the Origin, Pathogenesis and Prevention of COVID-19”.
Prof. Zhou Hongwei shared diagnosis experience of COVID-19 at live broadcast.
Team of Prof. Hongwei Zhou published paper “Gut dysbiosis induces the development of pre-eclampsia through bacterial translocation” in Gut.
March 18, 2020
February 19, 2020
January 3, 2020